Navigation Links
Joint Venture Formed to Help Health Marketers Navigate Social Media Environment
Date:10/28/2009

NEW YORK, Oct. 28 /PRNewswire/ -- Extrovertic and Virilion announced today a joint venture, EV Healthcare, to help healthcare companies engage consumers in an increasingly social communications environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091028/PH00703LOGO )

"Innovating to meet the perpetually evolving needs of digital, social and mobile consumers is hard enough," says Dorothy Wetzel, co-founder and executive marketer at Extrovertic. "Doing it in the politically and emotionally charged healthcare arena is the ultimate challenge. But with Virilion's more than a decade of experience dealing with cause-related issues and crisis management, this venture greatly enhances our ability to create new 'pharma-safe' solutions that build brands."

"Virilion has long specialized in digital and social media for categories in the public eye," said Dan Solomon, CEO of Virilion. "We believe this competence, combined with Extrovertic's deep healthcare knowledge and creative acumen, will help pharma clients more effectively engage consumers in today's changing communications environment."

"DTC advertising is under assault. Clients today need new non-traditional creative solutions to help them tell more cohesive and engaging stories across all channels," added Mark Drossman, Extrovertic's co-founder and executive creative director, "and in the process, create more engaged brand advocates."

Extrovertic was founded by industry veterans Dorothy Wetzel -- formerly of Saatchi Healthcare and Pfizer Consumer Marketing -- and Mark Drossman -- formerly of Ogilvy and Euro RSCG -- in January. The agency's client roster includes a number of biotech companies.

Virilion has offices in Austin, Boston, New York and Washington, DC. Since 1997, the firm has worked for clients in categories ranging from food, agriculture and energy to media and entertainment. In the healthcare sector, Virilion has worked for Abbott, the Pharmaceutical Manufacturers of America, and Easter Seals.

EV Healthcare will be led out of the firms' New York offices.

    CONTACT: Mimi Carter, Publicist
    VIRILION
    mcarter@virilion.com
    202.654.0800

SOURCE EV Healthcare


'/>"/>
SOURCE EV Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
2. Joint Commission Urges Patients to Speak Up About Pain
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
9. When to Have That Joint Replacement?
10. Beating Blood Clots after Joint Replacement
11. Octogenarians: Not Too Old for Joint Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):